Cargando…

Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine

PURPOSE OF REVIEW: A gap exists between PrEP interest and PrEP uptake in key populations (KP) for HIV prevention that may be ascribed to PrEP delivery services not being acceptable. This review summarizes novel platforms for HIV prevention outside of the traditional health facilities environment. RE...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousseau, E., Julies, R. F., Madubela, N., Kassim, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549812/
https://www.ncbi.nlm.nih.gov/pubmed/34708316
http://dx.doi.org/10.1007/s11904-021-00578-7
_version_ 1784590843864154112
author Rousseau, E.
Julies, R. F.
Madubela, N.
Kassim, S.
author_facet Rousseau, E.
Julies, R. F.
Madubela, N.
Kassim, S.
author_sort Rousseau, E.
collection PubMed
description PURPOSE OF REVIEW: A gap exists between PrEP interest and PrEP uptake in key populations (KP) for HIV prevention that may be ascribed to PrEP delivery services not being acceptable. This review summarizes novel platforms for HIV prevention outside of the traditional health facilities environment. RECENT FINDINGS: Mobile health clinics provide highly acceptable integrated, KP-focused services at convenient locations with the potential of high PrEP uptake. Telemedicine and health apps decongest health systems and allow for personal agency and informed decision-making on personal health. Pharmacy-led PrEP delivery provides de-medicalized, confidential PrEP services at extended hours in community locations, from trusted medical professionals. Peer-supported delivery encourages continued PrEP use. SUMMARY: Community-based, differentiated and de-medicalized PrEP delivery can address uptake and continued use barriers in key populations. Future research should assess scalability, cost-effectiveness and sustainability of these PrEP delivery platforms, as well as focus on ways to simplify PrEP provision.
format Online
Article
Text
id pubmed-8549812
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-85498122021-10-28 Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine Rousseau, E. Julies, R. F. Madubela, N. Kassim, S. Curr HIV/AIDS Rep The Science of Prevention (R Heffron and K Ngure, Section Editors) PURPOSE OF REVIEW: A gap exists between PrEP interest and PrEP uptake in key populations (KP) for HIV prevention that may be ascribed to PrEP delivery services not being acceptable. This review summarizes novel platforms for HIV prevention outside of the traditional health facilities environment. RECENT FINDINGS: Mobile health clinics provide highly acceptable integrated, KP-focused services at convenient locations with the potential of high PrEP uptake. Telemedicine and health apps decongest health systems and allow for personal agency and informed decision-making on personal health. Pharmacy-led PrEP delivery provides de-medicalized, confidential PrEP services at extended hours in community locations, from trusted medical professionals. Peer-supported delivery encourages continued PrEP use. SUMMARY: Community-based, differentiated and de-medicalized PrEP delivery can address uptake and continued use barriers in key populations. Future research should assess scalability, cost-effectiveness and sustainability of these PrEP delivery platforms, as well as focus on ways to simplify PrEP provision. Springer US 2021-10-27 2021 /pmc/articles/PMC8549812/ /pubmed/34708316 http://dx.doi.org/10.1007/s11904-021-00578-7 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle The Science of Prevention (R Heffron and K Ngure, Section Editors)
Rousseau, E.
Julies, R. F.
Madubela, N.
Kassim, S.
Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine
title Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine
title_full Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine
title_fullStr Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine
title_full_unstemmed Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine
title_short Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine
title_sort novel platforms for biomedical hiv prevention delivery to key populations — community mobile clinics, peer-supported, pharmacy-led prep delivery, and the use of telemedicine
topic The Science of Prevention (R Heffron and K Ngure, Section Editors)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549812/
https://www.ncbi.nlm.nih.gov/pubmed/34708316
http://dx.doi.org/10.1007/s11904-021-00578-7
work_keys_str_mv AT rousseaue novelplatformsforbiomedicalhivpreventiondeliverytokeypopulationscommunitymobileclinicspeersupportedpharmacyledprepdeliveryandtheuseoftelemedicine
AT juliesrf novelplatformsforbiomedicalhivpreventiondeliverytokeypopulationscommunitymobileclinicspeersupportedpharmacyledprepdeliveryandtheuseoftelemedicine
AT madubelan novelplatformsforbiomedicalhivpreventiondeliverytokeypopulationscommunitymobileclinicspeersupportedpharmacyledprepdeliveryandtheuseoftelemedicine
AT kassims novelplatformsforbiomedicalhivpreventiondeliverytokeypopulationscommunitymobileclinicspeersupportedpharmacyledprepdeliveryandtheuseoftelemedicine